Haemophilus influenzae type b- and meningococcal (vaccine)
Sponsors
GlaxoSmithKline
Conditions
Haemophilus Influenzae Type bNeisseria Meningitidis
Phase 3
Primary & Booster Immunogenicity Study of GSK Biologicals' Hib-MenC Versus a Licensed Men-C Vaccine
CompletedNCT00258700
Start: 2005-02-28End: 2006-07-31Updated: 2016-09-21
Safety, Reactogenicity & Immunogenicity Study to Evaluate a Booster Dose of GSK Biologicals' Hib-MenC Given With Priorix™ in Toddlers (13-14 m) Primed With 3 Doses of Hib and MenC-CRM197
CompletedNCT00263653
Start: 2005-03-31End: 2005-09-30Updated: 2016-09-21
Long-term Persistence Study to Assess a Booster Dose of GSK Biologicals' Hib-MenC
CompletedNCT00322335
Start: 2006-05-31End: 2010-09-30Updated: 2016-10-20
Study of a Booster Dose of Hib-MenC Conjugate Vaccine vs Infanrix Hexa When Given to 14 Month Old Subjects
CompletedNCT00323050
Start: 2004-11-30End: 2005-03-31Updated: 2016-09-16